Antibiotics: Neuropsychiatric Effects and Psychotropic Interactions

References

• Kunin CM. Problems in antibiotic usage. Principles and practice of infectious diseases.3rd ed., GL Mandell, RG Douglas, Jr, JE Bennett. Churchill Livingstone, New York 1990; 427–34
   Google Scholar
• Ricci S, Del Favero A, Longo VG. Central nervous system side-effects of anti-infectious drugs. Drugs Today 1986; 22: 283–300
   Google Scholar
• Gillum JG, Israel DS, Polk RE. Pharmacokinetic drug interactions with antimicrobial agents. Clin Pharmacokinet 1993; 25: 450–82
   PubMedGoogle Scholar
• Reese RE, Betts RF. Antibiotic use. A practical approach to infectious diseases.3rd ed., RE Reese, RF Betts. Little, Brown, Boston 1991; 271–93
   Google Scholar
• Little SC. Nervous and mental effects of the sulfonamides. JAMA 1942; 119: 467–74
   Google Scholar
• Kinsey RE. Psychosis due to sulfonamides. Ann Intern Med 1943; 19: 795–8
   Google Scholar
• Mermel LA, Doro JM, Kabadi UM. Acute psychosis in a patient receiving trimethoprim-sulfamethoxazole intravenously. J Clin Psychiatry 1986; 47: 269–70
   PubMed Web of Science ®Google Scholar
• Zealberg JJ, Lydiard RB, Christie S. Exacerbation of panic disorder in a woman treated with trimethoprimsulfamethoxazole [Letter]. J Clin Psychopharmacol 1991; 11: 144–5
   Google Scholar
• Desvilles M, Sevestre P. Effet paradoxal de l'association lithium et sulfamethoxazol-triméthoprime. Nouv Presse Med 1982; 11: 3267–8
   Google Scholar
• Bush LM, Calmon J, Johnson CC. Newer penicillins and beta-lactamase inhibitors. Infect Dis Clin North Am 1989; 3: 571–94
   PubMedGoogle Scholar
• Thomas RJ. Neurotoxicity of antibacterial therapy. South Med J 1994; 87: 869–74
   PubMed Web of Science ®Google Scholar
• Hodgman T, Dasta JF, Armstrong DK, Visconti JA, Reilley TE. Ampicillin-associated seizures. South Med J 1984; 77: 1323–5
   PubMed Web of Science ®Google Scholar
• Schliamser SE, Cars O, Norrby SR. Neurotoxicity of betalactam antibiotics: predisposing factors and pathogenesis. J Antimicrob Chemother 1991; 27: 405–25
   PubMed Web of Science ®Google Scholar
• Cohen MM. Fatality following the use of intrathecal penicillin: case report. J Neuropathol Exp Neurol 1952; 11: 335–9
   Google Scholar
• Seamans KB, Gloor P, Dobell RAR, Wyant JD. Penicillin-induced seizures during cardiopulmonary bypass: a clinical and electroencephalographic study. N Engl J Med 1968; 278: 861–8
   PubMed Web of Science ®Google Scholar
• Snavely SR, Hodges GR. The neurotoxicity of antibacterial agents. Ann Intern Med 1984; 101: 92–104
   PubMed Web of Science ®Google Scholar
• Kline CL, Highsmith LV. Toxic psychosis resulting after penicillin. Ann Intern Med 1948; 28: 1957–9
   Google Scholar
• Batchelar RCL, Home GO, Rogerson HL. An unusual reaction to procaine penicillin in aqueous suspension. Lancet 1951; 2: 195–8
   Google Scholar
• Björnberg A, Selstam J. Acute psychotic reaction after injection of procaine penicillin. Acta Psychiatr Neurol Scand 1960; 35: 129–39
   Google Scholar
• Ilechukwu STC. Acute psychotic reactions and stress response syndromes following intramuscular aqueous procaine penicillin. Br J Psychiatry 1990; 156: 554–9
   Google Scholar
• Utley PM, Lucas JB, Billings TE. Acute psychotic reactions to aqueous procaine penicillin. South Med J 1966; 59: 1271–4
   Google Scholar
• Tompsett R. Pseudoanaphylactic reactions to procaine penicillin G. Arch Intern Med 1967; 120: 565–7
   PubMedGoogle Scholar
• Kryst L, Wanyura H. Hoigné's syndrome—its course and symptomatology. J Maxillofac Surg 1979; 7: 320–6
   Google Scholar
• Silber TJ, D'Angelo L. Psychosis and seizures following the injection of penicillin G procaine: Hoigné's syndrome. Am J Dis Child 1985; 139: 335–7
   Google Scholar
• Kallay MC, Tabechian H, Riley GR, Chessin LN. Neurotoxicity due to ticarcillin in patient with renal failure [Letter]. Lancet 1979; 1: 608–9
   PubMed Web of Science ®Google Scholar
• Green RL, Lewis JE, Kraus SJ, Frederickson EL. Elevated plasma procaine concentrations after administration of procaine penicillin G. N Engl J Med 1974; 291: 223–6
   Google Scholar
• Downham TF, 2nd, Cawley RA, Salley SO, Eng D, Dal Santo G. Systemic toxic reactions to procaine penicillin G. Sex Transm Dis 1978; 51: 4–9
   Google Scholar
• Manku MS, Horrobin DF. Chloroquine, quinine, procaine, quinidine and clomipramine are prostaglandin agonists and antagonists. Prostaglandins 1976; 12: 789–801
   Google Scholar
• Araszkiewicz A, Florkowski A. Procaine kindling in, acute, non-allergic reaction to procaine penicillin G [In, Polish]. Psychiatr, Pol 1994; 28: 613–25
   Google Scholar
• Mintz U, Liberman UA, De Vries A. Parkinsonism syndrome due to cephaloridine. JAMA 1971; 216: 1200
   Google Scholar
• Saker BM, Musk AW, Haywood EF, Hurst PE. Reversible toxic psychosis after cephalexin. Med J Aust 1973; 1: 497–8
   PubMed Web of Science ®Google Scholar
• Wu MJ, Narsette TA, Hussey JL, Weinstein AB, Wen SF. Cephalothin neurotoxicity in renal failure [Letter]. Ann Intern Med 1978; 89: 429
   PubMed Web of Science ®Google Scholar
• Gabriel R, Foord RD, Joekes AM. Reversible encephalopathy and acute renal failure after cephaloridine. BMJ 1970; 4: 283–4
   Google Scholar
• Tollefson G. Neuropsychiatric sequelae and cephalothin [Letter]. J Clin Psychiatry 1984; 45: 96
   PubMed Web of Science ®Google Scholar
• Vinken W. Psychotic reaction to cefuroxime [Letter]. Lancet 1984; 1: 965
   Google Scholar
• Al-Zahawi MF, Sprott MS, Hendrick DJ. Hallucinations in association with ceftazidime. BMJ 1988; 297: 858
   PubMedGoogle Scholar
• Huri S, Kurioka S, Matsuda M, Shimada J. Inhibitory effect of cephalosporins on gamma-aminobutyric acid receptor binding in rat synaptic membranes. Antimicrob Agents Chemother 1985; 27: 650–1
   Google Scholar
• Horn JR, Hansten PD. Drug interactions with antibacterial agents. J Fam Pract 1995; 41: 81–90
   Google Scholar
• Birnbaum J, Kahan FM, Kropp H, MacDonald JS. Carbapenems, a new class of beta-lactam antibiotics: discovery and development of imipenem/cilastatin. Am J Med 1985; 78(6A)3–21
   PubMed Web of Science ®Google Scholar
• Calandra GB, Brown KR, Grad LC, Ahonkhai VI, Wang C, Aziz MA. Review of adverse experiences and tolerability in the first, 2, 516 patients treated with, imipenem/cilastatin. Am J Med 1985; 78(6A)73–8
   PubMed Web of Science ®Google Scholar
• Schliamser SE, Broholm KA, Liljedahl AL, Norrby SR. Comparative neurotoxicity of, benzylpenicillin, imipenem/cilastatin and FCE, 22101, a new injectable, penem. J Antimicrob, Chemother 1988; 22: 687–95
   PubMed Web of Science ®Google Scholar
• Eng RH, Munsif AN, Yangco BG, Smith SM, Chmel H. Seizure propensity with imipenem. Arch Intern Med 1989; 149: 1881–3
   PubMedGoogle Scholar
• Kane FJ, Jr, Byrd G. Acute toxic psychosis associated with gentamicin therapy. South Med J 1975; 68: 1283–5
   Google Scholar
• Byrd GJ. Acute organic brain syndrome associated with gentamicin therapy. JAMA 1977; 238: 53–4
   Google Scholar
• Mandell GL, Petri WA, Jr. Drugs used in the chemotherapy of, tuberculosisMycobacterium avium complex disease and leprosy. Goodman and Gilman's the pharmacological basis of therapeutics.9th ed., JG Hardman, LE Limbird, PB Molinoff, RW Ruddon, A Goodman Gilman. McGraw-Hill, New York 1996; 1155–74
   Google Scholar
• Holdiness MR. Neurological manifestations and toxicities of the antituberculosis drugs: a review. Med Toxicol 1987; 2: 33–51
   PubMedGoogle Scholar
• Reilly DK. Isoniazid-related CNS toxicity. Drug Ther 1979; 4: 187–8
   Google Scholar
• Robson JM, Sullivan FM. Antituberculosis drugs. Pharmacol Rev 1963; 15: 169–223
   PubMed Web of Science ®Google Scholar
• Schallek W, Walz D. Effects of isoniazid and iproniazid on the central nervous system of the dog. Am Rev Tuberc 1954; 69: 261–6
   Google Scholar
• Schmidt LH, Hoffman R, Hughes HB. The toxicity of isoniazid for the rhesus monkey. Am Rev Tuberc 1953; 67: 798–807
   Google Scholar
• Hunter RA. Confusional psychosis with residual organic cerebral impairment following isoniazid therapy. Lancet 1952; 2: 960–2
   Google Scholar
• Wiedorn WS, Ervin F. Schizophrenic-like psychotic reactions with administration of isoniazid. Arch Neurol Psychiatry 1954; 72: 321–4
   Google Scholar
• Bernardo M, Gatell JM, Parellada E. Acute exacerbation of chronic schizophrenia in a patient treated with antituberculosis drugs [Letter]. Am J Psychiatry 1991; 48: 1402
   Google Scholar
• Gnam W, Flint A, Goldbloom D. Isoniazid-induced hallucinosis: response to pyridoxine [Letter]. Psychosomatics 1993; 34: 537–9
   Google Scholar
• Bhatia MS. Isoniazid-induced obsessive compulsive neurosis [Letter]. J Clin Psychiatry 1990; 51: 387
   Google Scholar
• Zabad M. Psychosis with isoniazid therapy [Letter]. Lancet 1953; 1: 295
   Google Scholar
• Adams P, White C. Isoniazid-induced encephalopathy. Lancet 1965; 1: 680–2
   Google Scholar
• Cheung WC, Lo CY, Lo WK, Ip M, Chen IK. Isoniazid induced encephalopathy in dialysis patients. Tuber Lung Dis 1993; 74: 136–9
   Google Scholar
• Evans DAP, Manley KA, McKusick VA. Genetic control of isoniazid metabolism in man. Br Med J 1960; 2: 485–91
   PubMed Web of Science ®Google Scholar
• Ochs HR, Greenblatt DJ, Roberts GM, Dengler HJ. Diazepam interaction with antituberculosis drugs. Clin Pharmacol Ther 1981; 29: 671–8
   PubMed Web of Science ®Google Scholar
• Takeda M, Nishinuma K, Yamashita S, Matsubayashi T, Tanino S, Nishimura T. Serum haloperidol levels of schizophrenics receiving treatment for tuberculosis. Clin Neuropharmacol 1986; 9: 386–97
   Google Scholar
• Valsalan VC, Cooper GL. Carbamazepine intoxication caused by interaction with isoniazid. Br Med J (Clin Res Ed) 1982; 285: 261–2
   Google Scholar
• Wright JM, Stokes EF, Sweeney VP. Isoniazid-induced carbamazepine toxicity and vice versa: a double drug interaction. N Engl J Med 1982; 307: 1325–7
   PubMed Web of Science ®Google Scholar
• Radner DB. Toxicologic and pharmacologic aspects of rifampin. Chest 1973; 64: 213–6
   Google Scholar
• Brockmeyer NH, Mertins L, Klimek K, Goos M, Ohnhaus EE. Comparative effects of rifampin and/or probenecid on the pharmacokinetics of temazepam and nitrazepam. Int J Clin Pharmacol Ther Toxicol 1990; 28: 387–93
   Google Scholar
• Holmes VF. Rifampin-induced methadone withdrawal in AIDS, [Letter]. J Clin Psychopharmacol 1990; 10: 443–4
   PubMed Web of Science ®Google Scholar
• Kreek MJ, Garfield JW, Gutjahr CL, Giusti LM. Rifampin-induced methadone withdrawal. N Engl J Med 1976; 294: 1104–6
   PubMed Web of Science ®Google Scholar
• Mitchell RS, Lester W. Clinical experience with cycloserine in the treatment of tuberculosis. Scand J Respir Dis Suppl 1970; 71: 94–108
   Google Scholar
• Simeon J, Fink M, Itil TM, Ponce D. d-Cycloserine therapy of psychosis by symptom provocation. Compr Psychiatry 1970; 11: 80–8
   Google Scholar
• Hood WF, Compton RP, Monahan JB. d-Cycloserine: a ligand for the N-methyl-d-aspartate coupled glycine receptor has partial agonist characteristics. Neurosci Lett 1989; 98: 91–5
   PubMed Web of Science ®Google Scholar
• Goff DC, Tsai G, Manoach DS, Coyle JT. Dose-finding trial of d-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am J Psychiatry 1995; 152: 1213–5
   PubMed Web of Science ®Google Scholar
• Cascella NG, Macciardi F, Cavallini C, Smeraldi E. d-Cycloserine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label study. J Neural Transm Gen Sect 1994; 95: 105–11
   Web of Science ®Google Scholar
• Rosse RB, Fay-McCarthy M, Kendrick K, Davis RE, Deutsch SI. d-Cycloserine adjuvant therapy to molindone in the treatment of schizophrenia. Clin Neuropharmacol 1996; 19: 444–50
   Google Scholar
• Van Berckel BNM, Hijman R, Van der Linden JA, Westenberg HGM, Van Ree JM, Kahn RS. Efficacy and tolerance of d-Cycloserine in drug-free schizophrenic patients. Biol Psychiatry 1996; 40: 1298–300
   PubMed Web of Science ®Google Scholar
• Weinstein HJ, Hallett WY, Sarauw AS. The absorption and toxicity of ethionamide. Am Rev Respir Dis 1962; 86: 576–8
   PubMed Web of Science ®Google Scholar
• Lees AW. Ethionamide, 750 mg daily, plus isoniazid, 450 mg daily, in previously untreated cases of pulmonary tuberculosis. Am Rev Respir Dis 1965; 92: 966–9
   Google Scholar
• Gedroyc W, Shorvon SD. Acute intracranial hypertension and nalidixic acid therapy. Neurology 1982; 32: 212–5
   Web of Science ®Google Scholar
• Frazer M, Gault R. Death as a result of an adverse reaction from nalidixic acid. J Forensic Sci 1986; 31: 1145–9
   Google Scholar
• Staudenbauer WL. Replication of Escherichia coli DNA in vitro: inhibition by oxolinic acid. Eur J Biochem 1976; 62: 491–7
   PubMedGoogle Scholar
• Gleckman R, Alvarez S, Joubert DW, Matthews SJ. Drug therapy reviews: oxolinic acid. Am J Hosp Pharm 1979; 36: 1077–9
   Google Scholar
• Christ W. Central nervous system toxicity of quinolones: human and animal findings. J Antimicrob Chemother 1990; 26: 219–25, suppl B
   PubMedGoogle Scholar
• Cohen AI, Rein MF, Noble RC. A comparison of rosoxacin with ampicillin and probenecid in the treatment of uncomplicated gonorrhea. Sex Transm Dis 1984; 11: 24–7
   Google Scholar
• Zaudig M, Von Bose M, Weber MM, Bremer D, Zieglgäns-Berger W. Psychotoxic effects of ofloxacin. Pharmacopsychiatry 1989; 22: 11–5
   PubMed Web of Science ®Google Scholar
• Altés J, Gascó J, De Antonio J, Salas A, Villalonga C. Ciprofloxacin and delirium [Letter]. Ann Intern Med 1989; 110: 170–1
   Google Scholar
• Reeves RR. Ciprofloxacin-induced psychosis. Ann Pharmacother 1992; 26: 930–1
   PubMed Web of Science ®Google Scholar
• Mulhall JP, Bergmann LS. Ciprofloxacin-induced acute psychosis. Urology 1995; 46: 102–3
   Google Scholar
• Feinberg SS. Fluoroquinolone-induced depression [Letter]. Am J Psychiatry 1995; 152: 954–5
   Google Scholar
• Radandt JM, Marchbanks CR, Dudley MN. Interactions of fluoroquinolones with other drugs:, mechanismsvariability, clinical significance, and management. Clin Infect Dis 1992; 14: 272–84
   PubMed Web of Science ®Google Scholar
• Davies BI, Maesen FP. Drug interactions with quinolones. Rev Infect Dis 1989; 11: S1083–90, suppl 5
   Google Scholar
• Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996; 153: 311–20
   PubMed Web of Science ®Google Scholar
• Kamali F, Thomas SHL, Edwards C. The influence of steady-state ciprofloxacin on the pharmacokinetics and pharmacodynamics of a single dose of diazepam in healthy volunteers. Eur J Clin Pharmacol 1993; 44: 365–7
   Google Scholar
• Tracy JW, Webster LT, Jr. Drugs used in the chemotherapy of protozoal infections. Goodman and Gilman's the pharmacological basis of therapeutics.9th ed., JG Hardman, LE Limbird, PB Molinoff, RW Ruddon, A Goodman Gilman. McGraw-Hill, New York 1996; 987–1008
   Google Scholar
• Holden JMC, Itil TM, Keskiner A. The effects of metronidazole on schizophrenic psychopathology. J Clin Pharmacol 1968; 8: 333–41
   Google Scholar
• Voth AJ. Possible association between metronidazole and agitated depression. Can Med Assoc J 1969; 100: 1012–3
   Google Scholar
• Giannini AJ. Side effects of metronidazole [Letter]. Am J Psychiatry 1977; 134: 329–30
   PubMed Web of Science ®Google Scholar
• Alvarez RS, Richardson DA, Bent AE, Ostergard DR. Central nervous system toxicity related to prolonged metronidazole therapy. Am J Obstet Gynecol 1983; 145: 640–1
   Google Scholar
• McCahill ME, Braff DL. Atypical postpartum psychosis possibly associated with metronidazole therapy. J Fam Pract 1988; 27: 323–5
   Google Scholar
• Brown JT. Metronidazole and panic attacks [Letter]. South Med J 1985; 78: 627
   Google Scholar
• Kusumi RK, Plouffe JF, Wyatt RH, Fass RJ. Central nervous system toxicity associated with metronidazole therapy. Ann Intern Med 1980; 93: 59–60
   PubMed Web of Science ®Google Scholar
• Alston TA. Neurotoxicity of metronidazole [Letter]. Ann Intern Med 1985; 103: 161
   Google Scholar
• Rothstein E, Clancy DD. Toxicity of disulfiram combined with metronidazole. N Engl J Med 1969; 280: 1006–7
   Google Scholar
• Teicher MH, Altesman RI, Cole JO, Schatzberg AF. Possible nephrotoxic interaction of lithium and metronidazole [Letter]. JAMA 1987; 257: 3365–6
   PubMedGoogle Scholar
• Patterson BD. Possible interaction between metronidazole and carbamazepine [Letter]. Ann Pharmacother 1994; 28: 1303–4
   Google Scholar
• Williams NR. Erythromycin: a case of nightmares [Letter]. Br Med J (Clin Res Ed) 1988; 296: 214
   Google Scholar
• Cohen IJ, Weitz R. Psychiatric complications with erythromycin. Br Med J 1976; 1: 1535
   Google Scholar
• Umstead GS, Neumann KH. Erythromycin ototoxicity and acute psychotic reaction in cancer patients with hepatic dysfunction. Arch Intern Med 1986; 146: 897–9
   Google Scholar
• Wallace RJ, Jr, Brown BA, Griffith DE. Drug intolerance to high-dose clarithromycin among elderly patients. Diagn Microbiol Infect Dis 1993; 16: 215–21
   PubMed Web of Science ®Google Scholar
• Nightingale SD, Koster FT, Mertz GJ, Loss SD. Clarith-romycin-induced mania in two patients with AIDS. Clin Infect Dis 1995; 20: 1563–4
   Google Scholar
• Carranco E, Kareus J, Co S, Peak V, Al-Rajeh S. Carbamazepine toxicity induced by concurrent erythromycin therapy. Arch Neurol 1985; 42: 187–8
   Google Scholar
• Hiller A, Olkkola KT, Isohanni P, Saarnivaara L. Unconsciousness associated with midazolam and erythromycin. Br J Anaesth 1990; 65: 826–8
   PubMed Web of Science ®Google Scholar
• Olkkola KT, Aranko K, Luurila H, Hiller A, Saarnivaara L, Himberg JJ, et al. A potentially hazardous interaction between erythromycin and midazolam. Clin Pharmacol Ther 1993; 53: 298–305
   PubMed Web of Science ®Google Scholar
• Pollak PT, Sketris IS, MacKenzie SL, Hewlett TJ. Delirium probably induced by clarithromycin in a patient receiving fluoxetine. Ann Pharmacother 1995; 29: 486–8
   PubMed Web of Science ®Google Scholar
• Von Rosensteil NA, Adam D. Macrolide antibacterials: drug interactions of clinical significance. Drug Safety 1995; 13: 105–22
   PubMed Web of Science ®Google Scholar
• Idzikowski C, Oswald I. Interference with human memory by an antibiotic. Psychopharmacology 1983; 79: 108–10
   PubMed Web of Science ®Google Scholar
• Flexner LB, Serota RG, Goodman RH. Cycloheximide and acetoxycycloheximide: inhibition of tyrosine hydroxylase activity and amnestic effects. Proc Natl Acad Sci USA 1973; 70: 354–6
   Google Scholar
• Kofman O, Klein E, Newman M, Hamburger R, Kimchi O, Nir T, et al. Inhibition by antibiotic tetracyclines of rat cortical noradrenergic adenylate cyclase and amphetamine-induced hyperactivity. Pharmacol Biochem Behav 1990; 37: 417–24
   Google Scholar
• Belmaker RH, Roitman G. A clinical trial of demethylchlortetracycline as lithium-like agent in excited psychoses. Lithium: inorganic pharmacology and psychiatric use, NJ Birch. IRL Press, OxfordEngland 1988; 191–3
   Google Scholar
• Levine J, Cholestoy A, Zimmerman J. Possible antidepressant effect of minocycline [Letter]. Am J Psychiatry 1996; 153: 582
   PubMed Web of Science ®Google Scholar
• Stoudemire A, Moran MG, Fogel BS. Psychopharmacology in the medically ill patient. The American Psychiatric Press textbook of psychopharmacology, AF Schatzberg, CB Nemeroff. American Psychiatric Press, Washington, DC 1995; 783–801
   Google Scholar
• McGennis AJ. Lithium carbonate and tetracycline interaction. Br Med J 1978; 1: 1183
   PubMed Web of Science ®Google Scholar
• Miller SC. Doxycycline-induced lithium toxicity [Letter]. J Clin Psychopharmacol 1997; 17: 54–5
   Google Scholar
• Singer I, Rotenberg D. Demeclocycline-induced nephrogenic diabetes insipidus: in-vivo and in-vitro studies. Ann Intern Med 1973; 79: 679–83
   Google Scholar
• Forrest JN, Jr, Cox M, Hong C, Morrison G, Bia M, Singer I. Superiority of demeclocycline over lithium in the treatment of chronic syndrome of inappropriate secretion of antidiuretic hormone. N Engl J Med 1978; 298: 173–7
   PubMed Web of Science ®Google Scholar
• Goldman MB, Luchins DJ. Demeclocycline improves hyponatremia in chronic schizophrenics. Biol Psychiatry 1985; 20: 1149–55
   Google Scholar